HTLV I & II ANTIBODIES^

The HTLV I & II Antibodies test detects immune response to Human T‑lymphotropic Virus types I and II by screening blood for specific antibodies, using a serum sample collected at home by a trained phlebotomist. Ideal for blood donors, people with potential exposure, pregnant women from endemic areas, or patients with unexplained neurological or hematologic symptoms, this service offers discreet home collection and processing in UAE‑accredited laboratories for fast, reliable results. Positive screening results require confirmatory testing and clinical follow‑up, so discuss any findings with your physician to ensure appropriate management and reporting under UAE healthcare protocols.

• HTLV I Antibodies (IgG)
• HTLV II Antibodies (IgG)
• Combined HTLV I/II Antibody Screen
• Reflex confirmatory testing (Western Blot / PCR) for reactive samples
• Sample type: Serum / Plasma (venous)

• High-sensitivity serologic screening for HTLV‑I and HTLV‑II antibodies
• Discreet home blood collection by trained phlebotomists across Dubai and the UAE
• Processed in UAE‑accredited laboratories with secure, confidential results
• Fast turnaround with clear digital reports, pricing in AED and insurance support options
• Suitable for blood-donor, prenatal, or exposure-risk screening with local follow-up referrals

• Sensitive detection of antibodies to HTLV‑I and HTLV‑II for early identification of prior exposure
• Home sample collection by certified phlebotomists or validated self‑collection kit for comfort and convenience
• Processed in UAE‑accredited laboratories using high‑sensitivity assays for reliable screening
• Confidential, physician‑reviewed digital report with clear guidance on confirmatory testing and next steps
• Suitable for routine screening, pre‑donation or pre‑travel checks with discreet scheduling and privacy‑compliant handling

• At-home venous blood collection by certified phlebotomists across Dubai and the UAE
• Laboratory screening for HTLV‑I and HTLV‑II antibodies performed in UAE‑accredited diagnostic centers
• Confidential electronic report with clinician-reviewed follow-up guidance, typically delivered within 48–72 hours
• Suitable for screening after potential exposure, blood-donor evaluation, or prenatal concern